OConnell Daniel Joseph 4
4 · Acumen Pharmaceuticals, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
OConnell Daniel Joseph
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2024-01-02+401,000→ 517,685 total - Award
Employee Stock Option (right to buy)
2024-01-02+602,000→ 602,000 totalExercise: $4.23Exp: 2034-01-01→ Common Stock (602,000 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date.
- [F2]The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date.